Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
1
x
$
30.00
Michael S. Clark, MD, PhD: The 5-HT1B Receptor: Behavioral Implications
1
x
$
30.00
Xin-Yun Lu, PhD, MD: Role of Central Melanocortin Signaling in Eating Disorders
1
x
$
30.00
Humberto Marin, MD: Special Issues in the Psychopharmacological Management of Hispanic Americans
1
x
$
30.00
Paul E. Keck, Jr., MD: Definition, Evaluation, and Management of Treatment Refractory Mania
1
x
$
30.00
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
1
x
$
30.00
Philip T. Ninan, MD: Pharmacokinetically Induced Benzodiazepine Withdrawal
1
x
$
30.00
Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence
1
x
$
30.00
View Cart
Checkout
Home
study-design
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
$
30.00
Add to cart
Details
Page load link
Go to Top
